MAFLD definition underestimates the risk to develop HCC in genetically predisposed patients
- 3 October 2021
- journal article
- letter
- Published by Wiley in Journal of Internal Medicine
- Vol. 291 (3) , 374-376
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The Health Impact of MAFLD, a Novel Disease Cluster of NAFLD, Is Amplified by the Integrated Effect of Fatty Liver Disease–Related Genetic VariantsClinical Gastroenterology and Hepatology, 2022
- Clinical utility of polygenic risk scores for predicting NAFLD disordersJournal of Hepatology, 2021
- Insights into contribution of genetic variants towards the susceptibility of MAFLD revealed by the NMR-based lipoprotein profilingJournal of Hepatology, 2021
- MAFLD identifies patients with significant hepatic fibrosis better than NAFLDLiver International, 2020
- MAFLD criteria overlooks a number of patients with severe steatosis: Is it clinically relevant?Journal of Hepatology, 2020
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statementJournal of Hepatology, 2020
- Mboat7 down-regulation by hyper-insulinemia induces fat accumulation in hepatocytesEBioMedicine, 2020
- Causal relationship of hepatic fat with liver damage and insulin resistance in nonalcoholic fatty liverJournal of Internal Medicine, 2017
- Genetics of nonalcoholic fatty liver diseaseMetabolism, 2016
- Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomesHepatology, 2015